The immune system strikes back: cellular immune responses against indoleamine 2,3-dioxygenase.
<h4>Background</h4>The enzyme indoleamine 2,3-dioxygenase (IDO) exerts an well established immunosuppressive function in cancer. IDO is expressed within the tumor itself as well as in antigen-presenting cells in tumor-draining lymph nodes, where it promotes the establishment of periphera...
Main Authors: | Rikke Baek Sørensen, Linda Berge-Hansen, Niels Junker, Christina Aaen Hansen, Sine Reker Hadrup, Ton N M Schumacher, Inge Marie Svane, Jürgen C Becker, Per thor Straten, Mads Hald Andersen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-09-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19738905/?tool=EBI |
Similar Items
-
Characterization of Spontaneous Immune Responses against Long Peptides Derived from Bcl-X(L) in Cancer Patients Using Elispot
by: Mads Hald Andersen, et al.
Published: (2012-04-01) -
The Role of Indoleamine 2, 3-Dioxygenase in Immune Suppression and Autoimmunity
by: Jacques C. Mbongue, et al.
Published: (2015-09-01) -
Indoleamine-2,3-Dioxygenase as a Perioperative Marker of the Immune System
by: Corina Bello, et al.
Published: (2021-11-01) -
The role of indoleamine 2, 3 dioxygenase in regulating host immunity to leishmania infection
by: Makala Levi HC
Published: (2012-01-01) -
Regulation of the Immune Checkpoint Indoleamine 2,3-Dioxygenase Expression by Epstein–Barr Virus
by: Leila Sawada, et al.
Published: (2021-11-01)